SCHEMBL14051056

SCHEMBL14051056

CN1CCC(N(C)c2cc(N)n3ncc(Br)c3n2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 4/20 0.44
▸ CHEK1 O14757 2/20 0.44
▸ CCNA2 P20248 2/20 0.44
▸ CCNA1 P78396 2/20 0.44
▸ POLB P06746 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ NOS3 P29474 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ NOS2 P35228 1/20 0.35
▸ PDE1B Q01064 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ NSD2 O96028 1/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ WNT1 P04628 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11930869 0.79 CHEK1 (0.61) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL11930815 0.77 CDK2 (0.47) CDK2CHEK1CCNA2CCNA1SMN1; SMN2
SCHEMBL11930825 0.69 CDK2 (0.47) CDK2CHEK1CCNA2CCNA1MEN1
SCHEMBL13845460 0.68 CDK2 (0.50) CDK2CHEK1CCNA2CCNA1KMT2A
SCHEMBL11930818 0.68 HRH4 (0.49) CDK2CHEK1CCNA2CCNA1PIM1
SCHEMBL11930824 0.68 HRH4 (0.49) CDK2CHEK1CCNA2CCNA1PIM1
SCHEMBL14543100 0.67 HRH4 (0.53) —
SCHEMBL15146127 0.67 HRH4 (0.53) —
SCHEMBL12953557 0.66 CHEK1 (0.73) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL11930827 0.66 CDK2 (0.48) CDK2CHEK1CCNA2CCNA1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback